MYOM2 | Myomesin 2 | | | | | | Group enriched |
MFHAS1 | Malignant fibrous histiocytoma amplified sequence 1 | Disease related genes
| | | | | Expressed in all |
TNKS | Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase | Enzymes
| | | | | Expressed in all |
MSRA | Methionine sulfoxide reductase A | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PINX1 | PIN2/TERF1 interacting, telomerase inhibitor 1 | | | | | | Expressed in all |
FDFT1 | Farnesyl-diphosphate farnesyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CTSB | Cathepsin B | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PCM1 | Pericentriolar material 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
SH2D4A | SH2 domain containing 4A | | | | | | Mixed |
CSGALNACT1 | Chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Transporters
| | | | | Expressed in all |
POLR3D | Polymerase (RNA) III (DNA directed) polypeptide D, 44kDa | RNA polymerase related proteins
| | | | | Expressed in all |
SLC39A14 | Solute carrier family 39 (zinc transporter), member 14 | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PDLIM2 | PDZ and LIM domain 2 (mystique) | | | | | | Expressed in all |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
LOXL2 | Lysyl oxidase-like 2 | Enzymes Predicted secreted proteins
| | | | | Mixed |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
DOCK5 | Dedicator of cytokinesis 5 | | | | | | Mixed |
KCTD9 | Potassium channel tetramerization domain containing 9 | | | | | | Expressed in all |
CDCA2 | Cell division cycle associated 2 | | | | | | Tissue enhanced |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
DPYSL2 | Dihydropyrimidinase-like 2 | Plasma proteins
| | | | | Expressed in all |
TRIM35 | Tripartite motif containing 35 | | | | | | Expressed in all |
PTK2B | Protein tyrosine kinase 2 beta | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
EPHX2 | Epoxide hydrolase 2, cytoplasmic | Enzymes Plasma proteins
| | | | | Expressed in all |
CCDC25 | Coiled-coil domain containing 25 | | | | | | Expressed in all |
ESCO2 | Establishment of sister chromatid cohesion N-acetyltransferase 2 | Disease related genes
| | | | | Mixed |
INTS9 | Integrator complex subunit 9 | | | | | | Expressed in all |
HMBOX1 | Homeobox containing 1 | Transcription factors
| | | | | Expressed in all |
DUSP4 | Dual specificity phosphatase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enhanced |
DCTN6 | Dynactin 6 | | | | | | Expressed in all |
RBPMS | RNA binding protein with multiple splicing | | | | | | Expressed in all |
GTF2E2 | General transcription factor IIE, polypeptide 2, beta 34kDa | | | | | | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
WRN | Werner syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TTI2 | TELO2 interacting protein 2 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MAK16 | MAK16 homolog (S. cerevisiae) | | | | | | Expressed in all |
ERLIN2 | ER lipid raft associated 2 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
RAB11FIP1 | RAB11 family interacting protein 1 (class I) | | | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
LSM1 | LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) | | | | | | Expressed in all |
DDHD2 | DDHD domain containing 2 | Disease related genes
| | | | | Expressed in all |
KAT6A | K(lysine) acetyltransferase 6A | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
VDAC3 | Voltage-dependent anion channel 3 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
HOOK3 | Hook microtubule-tethering protein 3 | Cancer-related genes
| | | | | Expressed in all |
SPIDR | Scaffolding protein involved in DNA repair | | | | | | Expressed in all |
PRKDC | Protein kinase, DNA-activated, catalytic polypeptide | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |